å»è¬åå ¬è¡šãããæŽå¯
çã®åŒåžåšçŸæ£æ²»çåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 20322025幎ã®USD 2.15åç±³ãã«ã§äŸ¡å€ããããšæšå®ããã2032幎ãŸã§ã«USD 3.67åç±³ãã«ã«éãããšäºæ³ãããŸãããããã£ãŒã«çã®åŒåžåšææç(BRD)ã®æ²»çã¯ãè«æ¯ã®ææãé²ãã管çããæ²»çããããã«èšèšãããç£å»è£œåã®ç¯å²ãå å²ããŸãã ãããã®ææçã¯ãäžè¬çã«ãŠã€ã«ã¹ãšçްèã®ç åäœã®çµã¿åããã«ãã£ãŠåŒãèµ·ããããŸã, å€ãã®å Žåã茞éãç°å¢ã®å€åãªã©ã®ã¹ãã¬ã¹èŠå ã«ãã£ãŠæªåããŸã.å©çšå¯èœãªè£œåã¯ããŠã€ã«ã¹ããã³çްèã®ä»£çåºãçŽ°èææãå¶åŸ¡ããããã«äœ¿çšãããæèçæ³ãããã³ç±ããã³èºã®ççãæžããã®ã«åœ¹ç«ã€æç... ãã£ãšèŠã
äž»èŠãªãã€ç å€åŠçåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 20322025幎ã«18.7åç±³ãã«ã«çžåœããäžççãªäž»èŠãªãã€ç å€åŠçåžå ŽèŠæš¡ã¯æšå®ããã2032幎ãŸã§ã«33.3åç±³ãã«ã«éãããšäºæ³ããã2025幎ãã2032幎ãŸã§ã®8.3%ã®ååç©ã®å¹Žéæé·ç(CAGR)ã瀺ãã ãã®å°è±¡çãªæ¥çèŠæš¡ãšäºæž¬ã¯ãäžççãªæé·çãšåŒ·åãããèšºææ©èœã«ãã£ãŠé§åãããå ç¢ãªåžå Žæé·ã匷調ããçŸåšãåç±³ã§ã¯éèŠãªæ¥çã·ã§ã¢ãä¿æããŠããŸãããããã£ãŒã«äž»èŠãªãã€ç å€(MDD)ã®åŠçœ®ã¯SSRIsãSNRIsãtricyclicã®æé¬±å€ãMAOIsããã³esketamineã®éŒ»ã®ã¹ãã¬ãŒã®ãããªããæ°ããéãæ©... ãã£ãšèŠã
ã°ããŒãã«å°¿è·¯ææçæ²»çåžå Žã¯ãè©äŸ¡ããããšæšå®ãããŸã 2025幎ã®USD 9.4 Bn å±ç€ºäºå® 3.20%ã®CAGR äºå ±æéäž (2025-2032)ãåãåããäžççãªå°¿è·¯ææçæ²»çåžå Žã¯ãäžçäžã®ç³å°¿ç ãšè èã®ç³ã®é«åçã«ãã匷åãªæé·ãçµéšããŠããŸãã ãŸããå°¿è·¯ææç(UTI)ã®äºé²å¹æãé«ããäžçåå°ã®èã®äººå£ãå¢å ãããããšã§ãåžå Žã®æé·ãä¿ãããšãæåŸ ãããŠããŸãã ããããªãããUTIè¬ã®äœ¿çšã«é¢é£ããæªåœ±é¿ããäººã®æèã®æ¬ åŠãªã©ã®èŠå ã¯ãå°¿è·¯ææçã®æ²»çäžã®åžå Žã®æé·ã劚ããããšãæåŸ ãããŠããŸããã°ããŒãã«å°¿è·¯ææçæ²»çåžå Ž: å°åã€ã³ãµã€ãå°ççã«åºã¥ããŠãäžçç... ãã£ãšèŠã
Angina Pectoris æ²»çåžå ŽèŠæš¡ãšäºæž¬ â 2025 â 20322025幎ã®USD 9.45åç±³ãã«ã§ãäžçã¢ã³ã®ãã»ãã¯ããªã¹æ²»çåžå ŽèŠæš¡ãè©äŸ¡ããã2032幎ãŸã§ã®6.5%ã®ååç©ã®å¹Žéæé·ç(CAGR)ã2032åç±³ãã«ã«éãããšäºæ³ãããããããã£ãŒã«Angina pectoris ã¯èžã®çã¿ã軜æžããå¿èçºäœãé²ãããã«åŠçãããŸãã 管çã«ã¯ãå«ç ãããããããªã©ã€ãã¹ã¿ã€ã«ã®å€åãå¿ã®å¥åº·ã®é£äºã宿çãªéåãã¹ãã¬ã¹ã®è»œæžãå«ãŸããŸãã ç¡é žå¡©(äŸãã°ããããã°ãªã»ãªã³)ãããŒã¿ãããã«ãŒãã«ã«ã·ãŠã ãã£ãã«ãããã«ãŒãæè¡å°æ¿å€(äŸãã°ãã¢ã¹ããªã³)ãããã³ã¹ã¿... ãã£ãšèŠã
ã°ããŒãã«ã»ã€ã³ãã©ããã¢ã¹ã»ãœãªã¥ãŒã·ã§ã³åžå Žãè©äŸ¡ããããšæšå®ããã ç±³ãã« 11.05 2025幎ã®Bn CAGRåºå±äºå® 6.3% äºå ±æéäž (2025-2032). éèå æº¶æ¶²(IV)ã¯ãç ç³ãå¡©ãæ°ŽãçŽæ¥éè埪ç°ã«æäŸããæ£è ã«æäžãããŸãã IVã®è§£æ±ºããã³é»è§£ç©ã¯æ¶²äœã®èçã宿çãªç¶æãåãæ¿ãããã³åé åã®ããã«äœ¿çšãããŸãã æè¿ãéèå è¬ãæ é€ããã³æ··åããã解決ã¯çŸä»£çæ³ã®å¿ èŠãªéšåã«ãªããŸããã æäžã®éèå çµè·¯ã¯ãäžè¬çã«ãåæ°Žã®ããã«äœ¿çšããããããŸãã¯äžå¯èœãªäººã®ããã®æ é€çŽ ãæäŸãããããŸãã¯ç²Ÿç¥ç¶æ ãäœäžããããããŸãã¯ããã§ãªããã°ãé£ç©ãŸãã¯æ°Žãå£ã§... ãã£ãšèŠã
è žæ é€åžå Žã¯ã2025幎ã«USD 3.47 Bnã§è©äŸ¡ããã2032幎ã«USD 5.15 Bnã«éãããšäºæ³ããã2025ãã2032ãŸã§ã®ååç©ã®å¹Žéæé·ç(CAGR)ãå±ç€ºããŠããŸãã ããã®çºççãå¢å ããåæã®åºç£åæ°ãå¢å ãããšãåžå Žæé·ãæåŸ ãããŸããã°ããŒãã«è žæ é€åžå Žã«é¢ããã¢ããªã¹ãã®æèŠ:è žã®æ é€ãå¥å管äŸçµŠã¯ãèãå°ããè žã«æ é€ãçŽæ¥æž¡ãæ¹æ³ã§ãã é£ãå¥äžãå°é£ãªå¹Žéœ¢å±€ã®å¢å ã¯ãåžå Žæé·ãä¿ãããšãæåŸ ãããŠããŸãã ãããã£ãŠãé«éœ¢è ã®å¢å ã¯ãäºæž¬æéã«ããã£ãŠåžå Žã®ããã®éèŠãªæé·æ©äŒã瀺ãããšãæåŸ ãããŸãå³1. ã°ããŒãã«è žæ é€åžå Žã·ã§ã¢(%)ã補åã®çš®é¡ã20... ãã£ãšèŠã
æè¡çšæ¥çå€åžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032æè¡çšã°ã«ãŒã¹åžå ŽèŠæš¡ãè©äŸ¡ããããšæšå®ããã 2025幎ã®USD 1.9å ãããŠå°éããäºå® 2032幎ãŸã§ã®USD 3.4åãæ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ã®å±ç€º 8.3%(çšæ) 2025幎ïœ2032幎ãããã£ãŒã«å€ç§æ¥çå€ã¯ãŸãå€ç§æ¥çå€ãšããŠç¥ãããŠãããããŸãã¯å¯å°å€ã¯å éšãå€çãªãã£ãã·ã¥ãäžç·ã«ä¿®çããããã«å€å·ã®å·å®³ãå€ç§ã®åŸã§äœ¿çšãããŸãã å€ç§æ¥çå€ã¯ããã£ãªãŒã®æ¶²äœã®æµãã忢ããéå£ãšããŠãã£ãã·ã¥ãäžç·ã«æ¡ãããã«ååŠçµæã䜿çšããã®ã§å·ã®ééã®ããã®åªç§ãªææã§ãã çž«åãã¹ããŒãã«ãªã©ã®åŸæ¥ã®ã¢ãããŒããã... ãã£ãšèŠã
éé管ç åžå ŽèŠæš¡ãšäºæž¬ â 2025 â 2032éé管çåžå ŽèŠæš¡ãè©äŸ¡ããããšæšå®ããã 2025幎ã®USD 35.6å ãããŠå°éããäºå® 2032幎ãŸã§ã®USD 59.8åãæ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ã®å±ç€º 7.8% 2025幎ïœ2032幎ãããã£ãŒã«äœé管çã¯ãå¥åº·ãªã©ã€ãã¹ã¿ã€ã«ãç¶æããç¶æããããã®ã¢ãããŒãã§ãã äœé管çã«ã¯ããšãã«ã®ãŒæåéãšãšãã«ã®ãŒæ¯åºãç¶æããããã«ããã©ã³ã¹ã®åããé£äºçæ³ãšç©ççãªéåãå«ãŸããŠããŸãã å¥åº·çãªé£ç¿æ £ãæã€å人ã¯ãé£åã®æ¶è²»éãšæ¶è²»éãæããããšãã§ããŸãã éãããã³äžæçãªæžéãä¿é²ãã飌æã¯éé管çã«å«ãŸããŠããŸããã... ãã£ãšèŠã
åžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032Laxativesã®åžå ŽèŠæš¡ã¯è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®USD 4.8å ãããŠå°éããäºå® 2032幎ãŸã§ã®USD 7.5åãæ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ã®å±ç€º 6.2% 2025幎ïœ2032幎ãããã£ãŒã«ä¹³å€ã¯äŸ¿ã®éåããã³è žã®åããå¢å ããã®ã«æçšã§ããååŠç©è³ªã§ãããåŸã£ãŠã䟿ç§ãæ±ãã/ãŸãã¯é²ãã®ã«äœ¿çšãããŠããŸãã ä¹³é žå€ãäž»ã«æ²»çã®ããã«äœ¿çšããã䟿ç§ã®çºçããã³å¢å ã®çºççãä¹³å€ã®æ¶è²»ã®å¢å ã«ã€ãªãããããããªããããã³ããæ ãä¹³å€ã®åžå Žæé·ãããããããšãã§ããé£é害ãªã©ã®å»çé害ã®å¢å ã®å¢å ã®å¢å ã çµæå€ã®åŠæ¹çšé... ãã£ãšèŠã
2025幎ã®USD 9.71 Bnã§è©äŸ¡ãããmyeloproliferative Neoplasmsã®åŠçœ®ã®åžå Žã¯USD 12.69ã«éãããšæåŸ ãããŸã 2032幎ã«Bnã2025幎ãã2032幎ãŸã§ã®3.9%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºãGlobal Myeloproliferative Neoplasmsæ²»çåžå Žã«é¢ããã¢ããªã¹ãã®æèŠ:Myeloproliferative neoplasms(MPN)ã¯è¡æ¶²ã®çš®é¡ã§ã ããã°ã 骚é«ã®å¹¹çްèã®ç°åžžå€ç°(å€å)ããå§ãŸããŸãã å€åã¯ãçœçްèã赀现èãè¡å°æ¿ã®ããããçµã¿åããã®éå°çç£ã«ã€ãªããã Myeloprolifera... ãã£ãšèŠã
Muscular Dystrophyæ²»çåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032Muscular Dystrophyã®åŠçœ®ã®åžå Žã®ãµã€ãºã¯è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®USD 4.7å ãããŠå°éããäºå® 2032幎ãŸã§ã®USD 9.3åãæ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ã®å±ç€º 10.8% 2025幎ïœ2032幎çèDystrophyã®åŠçœ®ã®åžå Žã®åŸåçèæ§ãžã¹ãããã£ãŒã¯ãçèã®ç æ°ã®ã³ã¬ã¯ã·ã§ã³ã«ãã£ãŠç¹åŸŽä»ããããŸãã é害ã¯ãçèãæ§ç¯ããããã«å¿ èŠãªçèã¿ã³ãã¯è³ªæ¶å管ã®çç£ã劚ããéºäŒåå€ç°ã«ãã£ãŠåŒãèµ·ããããŸãã çèæ§ãžã¹ãããã£ãŒã¯éºäŒççŸæ£ã§ããããã®çµæãå人ã... ãã£ãšèŠã
ãªãœãã«é žãªããŒãŒæ¬ ææ²»çåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032Lysomalã®é žã®ãªããŒãŒã®æ¬ ä¹ã®åŠçœ®ã®åžå Žã®ãµã€ãºã¯ã§è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®USD 420,000,000 ãããŠå°éããäºå® 2032幎975äžãã«ãæ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ã®å±ç€º 12.8%(çšæ) 2025幎ïœ2032幎åžå ŽæŠèгLysomalã®é žã®ãªããŒãŒ(LAL)ã®äžè¶³ã¯ããã£ãååãªlysomalã®é žã®ãªããŒãŒ(LAL)ã®é µçŽ ãäœãåºãããšãã§ããªããŸããªç¶æ¿ãããç¶æ ã§ããèèªææã®åè§£ã®ããã®éèŠãªé µçŽ ã¯ããªãã¡ã³ã¬ã¹ããªã«ã®ãšã¹ãã«ããã³ããªã°ãªã»ãªããã§ãã ãã®çµæã¯ãèŸèãèèã... ãã£ãšèŠã
ã·ã¹ããªãã€ã· æ²»çåžå ŽèŠæš¡ãšäºæž¬ - 2025 - 2032Schistosomiasisã®åŠçœ®ã®åžå Žã®ãµã€ãºã¯è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®USD 1.58å ãããŠå°éããäºå® 2032幎ãŸã§ã®USD 2.47åãæ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ã®å±ç€º 6.2% 2025幎ïœ2032幎Schistosomiasisã¯ãæ·¡æ°Žè«æ¯ã®ææã«ãã£ãŠåŒãèµ·ããããç æ°ã§ãã ããã¯äž»ã«å¯çã®ã¯ãŒã ã®è¡æµ(trematodeã®ã¯ãŒã )ã«ãã£ãŠåŒãèµ·ããããæ¥æ§ãæ ¢æ§ã®äŒæã§ããå ŽåããããŸãã è žãæ³å°¿åšãªã©ã®2ã€ã®åœ¢æ ããããŸãã 2017幎ã«äžçä¿å¥æ©é¢(WHO)ã®å ±åã«ãããšãæ³å°¿åšç§ã®... ãã£ãšèŠã
ãããã£ãŒã«ã©ã€ã ç ã¯ææçã®ç æ°ã§ãã, 现èã«èµ·å ãã â ãã¬ãªã¢ããŒã°ãã«ãã§ãª, ææãã倧人ã®é»éããã®ããããä»ããŠããã«éä¿¡ãããŸãã. ã»ãšãã©ã®äººéã®äŒæã¯nymphs (èªç¶ãã)ã®ãããã«ãã£ãŠåŒãèµ·ããããŸãã ãã£ãã¯ã¹ã¯äººäœã®äžéšã«åãä»ãã36ã48æéãã¹ãããã£ã«åãä»ããããå Žåãææãéä¿¡ã§ããŸãã é»ãããã¯ãç±³åœåæ±éšãäžåã¢ãã©ã³ãã£ãã¯ãããã³åäžå€®å°åã«ãããã©ã€ã ç ãåºãã責任ããããŸãããã ãã西æŽã®é»éããã¯ãå€ªå¹³æŽæ²¿å²žå°åã®ã©ã€ã ç ãåºããã ãããã®å°åã¯ãè¿ãå°æ¥ã«ã©ã€ã ç ã®æ²»çã®ããã®åžå Žã®æ¥éãªæé·ãç®æããæåŸ ãããŠããŸããã©... ãã£ãšèŠã
æ¥éãªå»åŠã®èšºæãããã®åžå Žã®ãµã€ãºã¯éããããšãæåŸ ãããŸã US$ 51.53 å 2032, US$ 27.3 ãã 2025, CAGR ã§ 9.5% äºå ±æéäžã æ¥éãªèšºæãã¹ã(RDTs) äžããããåå ã蚺æããããšãç®çãšãããããã®ãã¹ã ã€ã³ãã©ã¡ãŒã·ã§ã³ åŸæ¥ã®ãã®ãããçŽæãå€§å¹ ã«ççž®ãããŸããæ¥éãªå»åŠã®èšºæãããã®åžå Žå°åã®æŽå¯:åã¢ã¡ãªã« 2025幎ã®åžå Žã·ã§ã¢ã®47%以äžãå ãããäºæž¬æéäžã«æ¥éãªå»ç蚺æãããã®åžå Žã®ããã®æå€§ã®åžå Žã§ããããšãæåŸ ãããŸãã åç±³ã§ã®åžå Žã®æé·ã¯ã補åã®çºå£²ãå¢å ãããå¯èœæ§ããããŸããã€ã³ãã©ã¡ãŒã·ã§ã³ ãšãŒããã åžå Ž... ãã£ãšèŠã
ãããã£ãŒã«Ambulatory ã±ã¢ã¯ãå ¥é¢ãä»ã®å»çæœèšãªãã§ã倿¥æ£è ã«æäŸãããå»çãµãŒãã¹ãæããŸãã å»åž«ãæ¯ç§å»äºåæãå»çåŸäºè ãå®¶åºå»çãªã©ã®ãµãŒãã¹ãæäŸããŠããŸãã Ambulatoryã±ã¢ãµãŒãã¹ã¯ãç é¢ã®åçãšå»çã·ã¹ãã ã®ããã©ãŒãã³ã¹ãžã®äž»èŠãªè²¢ç®ã®äžã€ã§ãã Ambulatory ã±ã¢ã¯ãé«åºŠãªå»çåŠçœ®ãæ£è ã«èšºæã芳å¯ãçžè«ãæ²»çãä»å ¥ããªãããªããŒã·ã§ã³ãµãŒãã¹ãæäŸããŠããŸãã ãŸããé»è©±çžè«ããªãããªããŒã·ã§ã³èšªåãããã³æ£è ãžã®ç·æ¥èšªåã¯ãããå€ãã®æ£è ããµãŒãã¹ã«åŒãå¯ããããšãæåŸ ããã財æ¿çãªçµæãžã®å€§ããªè²¢ç®ãæäŸããŸããAmbulatory ... ãã£ãšèŠã
å°å ç§ã®åžå ŽèŠæš¡ã®äžççãªé²é£è¬ã¯éããããšãæåŸ ãããŸã US$ 2,034.7 Mn ãã 2032, US$ 1,202.4 2025幎ã®Mnã8.0%ã®æ··åç©ã®å¹Žæ¬¡æé·ç(CAGR)ãå±ç€ºããŸã äºå ±æéäžãã°ããŒãã«é²è å€ Pediatrics ããŒã±ããã®å°åæŽå¯ã®ããã®è¬åç±³ã¯ãäºæž¬æéäžã®å°å åžå Žã§ã®æé²è è¬åžå Žã§æå€§ã®åžå Žã·ã§ã¢ãå ããèŠèŸŒã¿ã§ã2025幎ã®åžå Žã·ã§ã¢ã®41.3%以äžãå ããŠããŸãã åã¢ã¡ãªã«ã®åžå Žã®æé·ã¯ãäžæç²Ÿç¥ãæå©ãªåéãäž»èŠãªãã¬ãŒã€ãŒã®ååšã®é«åªå é äœã«ãããã®ã§ããæ¬§å·ã¯ãå°å åžå Žã§ã®é²é£è¬ã®2çªç®ã«å€§ããå°åã§ããããšãæåŸ ããã2025幎ã®... ãã£ãšèŠã
ãããã£ãŒã«çè·ã±ã¢ãµãŒãã¹ã¯ãããŒãã³ãœã³ç ãã¢ã«ããã€ããŒç ãæªæã®äžè©±ãå¿ èŠãªæ£è ãç æ°ã®æ£è ãããã³ç¶ç¶çãªåºåžãå¿ èŠãšããæ£è ãªã©ã®æ ¢æ§çŸæ£ã«èŠããã§ããæ£è ã«ç¹å¥ãªã±ã¢ãæäŸããŸãã ä»è·ãµãŒãã¹ã»ã³ã¿ãŒã§ã¯ããã¬ãŒãã³ã°ãåããå°éå®¶ãããã¬ãã·ã³ã°ãããŒãœãã«è¡çãã¿ã€ã ãªãŒãªè¬ãªã©ã®ã±ã¢æœèšãæäŸããŠããŸãã ãã®æ¥çã¯ãæ£è ã®çè·ããªãããªããŒã·ã§ã³ãµãŒãã¹ãããã³äžéšã®é害è ãæ ¢æ§é害ãæã€äººã ã«å®¿æ³æœèšãæäŸããŸãã ãããã®ãµãŒãã¹ã»ã³ã¿ãŒã§ã¯ãã¹ããŒãã»ã©ãã¹ãã身äœçã»ã©ãã¹ãã®å©ããåããä»å ¥è¬ãç£èŠããŸããä»è·ãµãŒãã¹åžå ŽèŠæš¡ãšäºæž¬ â 2025 â 2032... ãã£ãšèŠã